Authors

Building Agility and Adaptability Into Pharma Operations

Why driving results from such strategies—amid industry disruption—will be critical to success.

Congress Revives Push to Digitize Prescription Information

New bipartisan legislation would give the FDA authority to modernize prescribing information, reducing waste while improving accuracy and patient care.

2025 Pharma Forecast: Four Pivotal Trends Revolutionizing Market Access Strategies

Building Agility and Adaptability Into Pharma Operations

Why driving results from such strategies—amid industry disruption—will be critical to success.

Lilly Agreement With Trump Administration Reshapes Patient Access to GLP-1 Obesity Medicines

Lilly announced a new agreement with the Trump administration to expand access to its GLP-1 therapies, including Zepbound and orforglipron, offering the drugs to Medicare beneficiaries for $50 per month and through Medicaid programs starting in 2026.

Beyond the Brand Team: Why Every Employee Needs to Be Part of the Journey

Engaging the full workforce—from HR to R&D—can elevate launch outcomes, build trust, and create long-term brand ambassadors.

Forecasting the 2025 Healthcare Logistics Space

How will supply chains in the space continue to develop?

Why AI Advances in CGT Require Getting Data Right

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program

Point of Care Lifts Reps Efforts

Point of Care and PatientPoint can improve the impact that your Pharma Reps are already having.

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead

Advice for pharma distributors and dispensers on what they should do now in order to solidify a secure supply chain.

Monitoring Payer-Level Performance and Planning

Payer-level reporting should do more than track performance—it must guide strategy, focus resources, and drive measurable brand impact.

Fair Market Value vs. Current Market Leverage

How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services

Why Pharmaceutical Products Need Sustainable Packaging

One packaging aspect—the tape—is often overlooked, but is a valuable component of the shipping process.

Innovation with GenAI: Lessons from Life Sciences and Beyond

By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.

Moving from Omnichannel to Optichannel Engagement Strategies: Your Questions Answered

Why the life science industry needs to move away from omnichannel marketing strategies and toward optichannel approaches that boost personalization and ROI in an era of shrinking budgets.

Innovation with GenAI: Lessons from Life Sciences and Beyond

By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.

Streamlining Clinical Trials with Site Augmentation

Imagine a world where clinical trials move seamlessly from concept to completion, staffing shortages are a thing of the past and patient recruitment happens at a record speed. Join Marken’s patient centric solutions expert and our featured guest for a dynamic discussion on how customizable site augmentation programs are accelerating life-saving treatments to market faster through scalable, flexible decentralized strategies. Learn practical solutions for streamlining on-site, remote or hybrid trials by matching dedicated clinical research professionals to your site’s unique needs, relieving staff burdens and empowering your team to focus on what matters most – patient care.

Staying Ahead of HIPAA

In fourth part of his Pharma Commerce video interview, Faisal Khan, a GRC solutions expert with Vanta, explains how tools like Vanta offer real-time visibility, safeguard patient data, and help prevent costly violations before they occur.

The GLP-1 Gold Rush: Why Compounded Alternatives Are a Risky Bet

Why startups and life sciences companies should approach this booming sector with extreme caution.

Empowering Patients as Partners: The Next Frontier for Pharma Companies

Life sciences organizations have an opportunity to move beyond patient-centered care and embrace a model that values lived experience, fosters collaboration, and positions patients as active contributors to research, treatment, and innovation.

To Be or Not to Be Material? That is the Question

Companies must assess illicit trade risks under a new EU directive, making materiality and compliance critical for sustainability reporting.

AI’s Next Step in Pharma Quality: From Detection to Closed-Loop Prevention

In the final part of his Pharma Commerce video interview, Shawn Opatka, VP and GM, Honeywell Life Sciences, explains that as pharma quality systems evolve, AI is shifting from reactive problem-solving to proactive, closed-loop risk prevention, enhancing operator insight, decision-making, and continuous process improvement.

Revolutionizing Pharma Patient Assistance Programs, KnippeRx Leads the Future of Patient Care

How the Rise in Self-Injectables Is Impacting Pharmaceutical Manufacturing

As the adoption of biologics rises, demand for home healthcare grows, and conditions like diabetes and autoimmune disorders become more prevalent, self-injectables are here to stay.

Technically Speaking: Quality Documentation is One of the Best Ways to Boost Performance

Why well-organized documentation is critical at every stage of the process.

Addressing the Threat of Prescription Abandonment

As the rising cost of prescription medications in the United States becomes an increasing barrier for millions of people, how can we effectively address and improve patient adherence?